Detection bias may explain raised bladder CA risk in T2DM

Detection bias may explain raised bladder CA risk in T2DM
Early detection bias may explain the pattern of increased bladder cancer risk previously reported in patients with type 2 diabetes, according to a study published online Aug. 29 in Diabetes Care.

(HealthDay)—Early detection bias may explain the pattern of increased bladder cancer risk previously reported in patients with type 2 diabetes, according to a study published online Aug. 29 in Diabetes Care.

Isabelle N. Colmers, from the University of Alberta in Edmonton, Canada, and colleagues used linked administrative databases (1996 to 2006) to create a cohort of 185,100 adults from British Columbia, Canada, with incident , who were age-, sex-, and index date-matched to individuals without in a 1:1 ratio. During annual time windows following the index date, the incidence rates and hazard ratios for bladder cancer were calculated.

During a median follow-up of four years, the researchers found that within the study population (54 percent men; average age, 60.7 years) 1,171 new bladder cancer cases were diagnosed. Bladder cancer incidence in the diabetes cohort was 85.3 per 100,000 person-years in the first year after diabetes diagnosis, compared with 66.1 in the control cohort (adjusted hazard ratio, 1.30; P = 0.03). The increased bladder cancer risk seen in the first year was limited to those with the fewest physician visits two years prior to the index date (?12 visits, adjusted hazard ratio, 2.14; P = 0.003). Type 2 diabetes was not associated with bladder cancer after the first year.

"The results suggest that early detection bias may account for an overestimation in previously reported increased risks of associated with type 2 diabetes," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Some diabetes drugs may increase risk of bladder cancer

Jul 03, 2012

An increased risk of bladder cancer is linked to the use of pioglitazone, a medication commonly used to treat type 2 diabetes, according to a new study published in CMAJ (Canadian Medical Association Journal).

Leukocyte telomere length linked to diabetes risk

Aug 23, 2013

(HealthDay)—For American Indians, leukocyte telomere length is associated with the risk of incident diabetes, with an almost two-fold increased risk for those with the shortest versus the longest length, ...

Recommended for you

Screening for diabetes at dental visits using oral blood

Feb 26, 2015

It is estimated that 8.1 million of the 29.1 million Americans living with diabetes are undiagnosed and many who have diabetes have poor glycemic control. Given that each year many Americans visit a dental provider but not ...

CBT, sertraline insufficient in diabetes and depression

Feb 26, 2015

(HealthDay)—For patients with diabetes and depression, improvements in depression are seen with cognitive behavioral therapy (CBT) or sertraline, with a significant advantage for sertraline, but glycemic ...

Early signs in young children predict type 1 diabetes

Feb 26, 2015

New research shows that it is possible to predict the development of type 1 diabetes. By measuring the presence of autoantibodies in the blood, it is possible to detect whether the immune system has begun to break down the ...

Daily menu plan reduces blood sugar significantly

Feb 25, 2015

A large group of people with diabetes who followed a menu plan created by University of Alberta nutrition researchers for just three months significantly reduced their blood sugar levels.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.